NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

VIMTA LABS LTD.

NSE : VIMTALABSBSE : 524394ISIN CODE : INE579C01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE523.80-9.6 (-1.8 %)
PREV CLOSE ( ) 533.40
OPEN PRICE ( ) 533.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3892
TODAY'S LOW / HIGH ( )518.40 538.10
52 WK LOW / HIGH ( )365 621.4
NSE523.05-9.4 (-1.77 %)
PREV CLOSE( ) 532.45
OPEN PRICE ( ) 532.45
BID PRICE (QTY) 523.05 (26)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 30441
TODAY'S LOW / HIGH( ) 518.00 537.85
52 WK LOW / HIGH ( )365.8 623.15
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 16-11 1990
Management Info
Sivalinga Prasad Vasireddi - Chairman Harita Vasireddi - Managing Director
Registered Office

Address Plot Nos 141/2 & 142,I D A Phase I I,Cherlapally, R R District,
Hyderabad,
Telangana-500051

Phone 040- 27264141

Email shares@vimta.com

Website www.vimta.com

Registrars Details
Cil Securities Ltd
214 Raghava Ratna Towers , Chirag Ali Lane,Abidas,,Hyderabad
 Listing : BSE, NSE, MCX
NEWS
01Apr Amalgamation
Inter alia, approved the Scheme of Amalgamation of Emtac Laboratories Pr..
02Mar Vimta Labs gets grants-in-aid from Min
Vimta Labs has received Grants-in-aid (GIA) of Rs 4.09 crore from Minist..
02Mar Vimta Labs informs about updates
Vimta Labs has informed regarding Grant in aid (GIA) of Rs 409.49 lakhs..
28Feb Announcement under Regulation 30 (LOD
Allotment of 5218 Equity shares under Vimta Labs Employee Stock Option P..
24Feb Vimta Labs informs about press release
With reference to letter no. VLL/Sh/089/2023-24 dated 23rd February 2024..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit94.55472.990000000001
Gross Profit 125.98 638.310000000001
Operating Profit 217.74970.150000000001
Net Sales 800.973151.16
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Ajanta Pharma (BSE)
 2377.00 (6.44%)
M.Cap (Rs. in Cr)29930.39
Alkem Laboratories (BSE)
 4899.45 (2.36%)
M.Cap (Rs. in Cr)58580.27
Astrazeneca Pharma I (BSE)
 5424.45 (1.70%)
M.Cap (Rs. in Cr)13561.13
Dr. Reddy's Lab (BSE)
 6349.95 (0.98%)
M.Cap (Rs. in Cr)105928.76
Torrent Pharma (BSE)
 2732.60 (2.20%)
M.Cap (Rs. in Cr)92483.60
MORE
Shareholding Pattern
NON-INSTITUTION 56.45%
PROMOTERS 36.92%
MUTUAL FUNDS/UTI 1.49%
FI/BANKS/INSURANCE 0.01%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.